\-\ Texto\\:\\ \ \(0\)\
\-\ ct\\ was\\ abnormal\ \(1\)\
\-\ well\\-circumscribed\\ lesion\\ off\\ inferior\\ aspect\\ right\\ lobe\\ of\\ the\\ liver\\ which\\ is\\ hyperattenuating\\ on\\ arterial\\ phases\\ imaging\\ and\\ becomes\\ isoattenuating\\ on\\ more\\ delayed\\ images\\.\\ \\ a\\ central\\ lower\\ attenuating\\ focus\\ can\\ be\\ seen\\ which\\ may\\ represent\\ the\\ \\"central\\ scar\\"\\.\ \(0\)\
\-\ note\\:\\ tc\\-99m\\ sulfur\\ colloid\\ scan\\ \\(not\\ included\\)\\ revealed\\ increased\\ uptake\\ in\\ this\\ region\\ in\\ relation\\ to\\ the\\ remainder\\ of\\ the\\ liver\\.\ \(0\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ fnh\\ \\(focal\\ nodular\\ hyperplasia\\)\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ fibrolamellar\\ hcc\ \(0\)\
\-\ hypervascular\\ metastatic\\ focus\ \(1\)\
\-\ 45\\ yo\\ woman\\ with\\ lower\\ abdominal\\ pain\ \(0\)\
\-\ although\\ a\\ hypoattenuating\\ central\\ scar\\ is\\ pathognomonic\\,\\ it\\ is\\ usually\\ seen\\ in\\ only\\ around\\ 50\\%\\ of\\ cases\\.\\ \\ the\\ central\\ scar\\ is\\ hypoattenuating\\ on\\ portal\\ venous\\ phase\\ imaging\\,\\ but\\ slowly\\ increases\\ in\\ attenuation\\ through\\ diffusion\\ of\\ the\\ contrast\\ agent\\ and\\ may\\ become\\ relatively\\ hyperattenuating\\ on\\ delayed\\ images\\.\ \(0\)\
\-\ a\\ large\\ percentage\\ of\\ lesions\\ may\\ show\\ one\\ of\\ more\\ atypical\\ features\\ \\(heterogenous\\ early\\ contrast\\ enhancement\\,\\ ill\\-defined\\ larger\\ lesions\\ on\\ arterial\\ scans\\,\\ hypoattenuating\\ portal\\ venous\\ phase\\ lesions\\ due\\ to\\ wash\\-out\\ effects\\,\\ compressed\\ parenchyma\\ surrounding\\ lesions\\ causing\\ a\\ hyperattenuating\\ rim\\ or\\ \\'pseudocapsule\\'\\)\\.\\ \\ in\\ these\\ cases\\,\\ confirmation\\ by\\ other\\ imaging\\ techniques\\ \\(tc\\-sulfur\\ colloid\\)\\ or\\ even\\ biopsy\\ is\\ indicated\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hyperattenuating\\:\\ 0\\.08781698238414085\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.08205207563378779\ \(0\)\
\-\ scar\\:\\ 0\\.06339539711768113\ \(0\)\
\-\ central\\:\\ 0\\.05330106837649212\ \(0\)\
\-\ colloid\\:\\ 0\\.047690320284817414\ \(0\)\
\-\ lesions\\:\\ 0\\.0433660759496483\ \(0\)\
\-\ portal\\:\\ 0\\.04263535839270321\ \(0\)\
\-\ \\'pseudocapsule\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ tc\\-sulfur\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.03990851410406073\ \(0\)\
\-\ phase\\:\\ 0\\.03810168605089817\ \(0\)\
\-\ isoattenuating\\:\\ 0\\.036573014859234074\ \(0\)\
\-\ focus\\:\\ 0\\.036386584659203074\ \(0\)\
\-\ arterial\\:\\ 0\\.035453503400309686\ \(0\)\
\-\ wash\\-out\\:\\ 0\\.03415204033901611\ \(0\)\
\-\ nodular\\:\\ 0\\.033975448408643714\ \(0\)\
\-\ delayed\\:\\ 0\\.032966638334267113\ \(0\)\
\-\ attenuating\\:\\ 0\\.030002899403689564\ \(0\)\
\-\ fnh\\:\\ 0\\.030002899403689564\ \(0\)\
\-\ sulfur\\:\\ 0\\.029623550078222566\ \(0\)\
\-\ venous\\:\\ 0\\.029400811549356677\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.029272327461380285\ \(0\)\
\-\ imaging\\:\\ 0\\.028465504613112834\ \(0\)\
\-\ percentage\\:\\ 0\\.02808126382023855\ \(0\)\
\-\ liver\\:\\ 0\\.02792627024485994\ \(0\)\
\-\ cases\\:\\ 0\\.02698398923204865\ \(0\)\
\-\ hcc\\:\\ 0\\.02671784167591731\ \(0\)\
\-\ may\\:\\ 0\\.0266492185151392\ \(0\)\
\-\ phases\\:\\ 0\\.026524372507574872\ \(0\)\
\-\ agent\\:\\ 0\\.025987269733608032\ \(0\)\
\-\ relation\\:\\ 0\\.025504887296120153\ \(0\)\
\-\ compressed\\:\\ 0\\.024666353134228786\ \(0\)\
\-\ confirmation\\:\\ 0\\.024296867155699346\ \(0\)\
\-\ techniques\\:\\ 0\\.02417984055574498\ \(0\)\
\-\ hypervascular\\:\\ 0\\.023954115205085003\ \(0\)\
\-\ increases\\:\\ 0\\.02373865371656957\ \(0\)\
\-\ effects\\:\\ 0\\.02363448828188343\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.023145463465602714\ \(0\)\
\-\ focal\\:\\ 0\\.0231326407975204\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.02287457050901528\ \(0\)\
\-\ slowly\\:\\ 0\\.021995882246781333\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.02192352455895769\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.021445777169754064\ \(0\)\
\-\ becomes\\:\\ 0\\.02119295261664841\ \(0\)\
\-\ heterogenous\\:\\ 0\\.02078057642238476\ \(0\)\
\-\ \\'\\:\\ 0\\.020560102414636454\ \(0\)\
\-\ more\\:\\ 0\\.02025759534893049\ \(0\)\
\-\ larger\\:\\ 0\\.019502550038739727\ \(0\)\
\-\ become\\:\\ 0\\.01929187817821445\ \(0\)\
\-\ remainder\\:\\ 0\\.01909017384447608\ \(0\)\
\-\ scans\\:\\ 0\\.018858940838933747\ \(0\)\
\-\ 45\\:\\ 0\\.01871082451900908\ \(0\)\
\-\ included\\:\\ 0\\.018674507586565626\ \(0\)\
\-\ off\\:\\ 0\\.018496983593509226\ \(0\)\
\-\ lower\\:\\ 0\\.01821670207927832\ \(0\)\
\-\ contrast\\:\\ 0\\.018130575230406686\ \(0\)\
\-\ diffusion\\:\\ 0\\.018128368896624465\ \(0\)\
\-\ even\\:\\ 0\\.018032621468579348\ \(0\)\
\-\ represent\\:\\ 0\\.017786366781703943\ \(0\)\
\-\ atypical\\:\\ 0\\.017552277893886043\ \(0\)\
\-\ indicated\\:\\ 0\\.017523813324880302\ \(0\)\
\-\ causing\\:\\ 0\\.017495518694612508\ \(0\)\
\-\ relatively\\:\\ 0\\.01732920912204725\ \(0\)\
\-\ parenchyma\\:\\ 0\\.017248192850202224\ \(0\)\
\-\ on\\:\\ 0\\.0171538154588964\ \(0\)\
\-\ rim\\:\\ 0\\.01714228148199371\ \(0\)\
\-\ features\\:\\ 0\\.017090200337085675\ \(0\)\
\-\ hepatic\\:\\ 0\\.016912295506189633\ \(0\)\
\-\ adenoma\\:\\ 0\\.016912295506189633\ \(0\)\
\-\ around\\:\\ 0\\.016862668492600555\ \(0\)\
\-\ attenuation\\:\\ 0\\.01628256431481535\ \(0\)\
\-\ uptake\\:\\ 0\\.01608996883741333\ \(0\)\
\-\ seen\\:\\ 0\\.016005948957987588\ \(0\)\
\-\ note\\:\\ 0\\.01563064231043503\ \(0\)\
\-\ images\\:\\ 0\\.015538046369188192\ \(0\)\
\-\ 50\\:\\ 0\\.015407573538596231\ \(0\)\
\-\ which\\:\\ 0\\.015119853907512311\ \(0\)\
\-\ early\\:\\ 0\\.014811179950912029\ \(0\)\
\-\ biopsy\\:\\ 0\\.014368214415340098\ \(0\)\
\-\ inferior\\:\\ 0\\.013740835835824944\ \(0\)\
\-\ \\(\\:\\ 0\\.013694061161021053\ \(0\)\
\-\ although\\:\\ 0\\.013677389955339354\ \(0\)\
\-\ \\)\\:\\ 0\\.013526780893143225\ \(0\)\
\-\ is\\:\\ 0\\.013324426028074066\ \(0\)\
\-\ surrounding\\:\\ 0\\.013313579451965714\ \(0\)\
\-\ revealed\\:\\ 0\\.012997506587043097\ \(0\)\
\-\ aspect\\:\\ 0\\.01272176272266994\ \(0\)\
\-\ show\\:\\ 0\\.012432018646879745\ \(0\)\
\-\ usually\\:\\ 0\\.01229823816998464\ \(0\)\
\-\ yo\\:\\ 0\\.01218650011043963\ \(0\)\
\-\ only\\:\\ 0\\.01217730643831723\ \(0\)\
\-\ abnormal\\:\\ 0\\.011550200191065932\ \(0\)\
\-\ through\\:\\ 0\\.011502165964079948\ \(0\)\
\-\ region\\:\\ 0\\.011438868375541767\ \(0\)\
\-\ scan\\:\\ 0\\.011337779433331653\ \(0\)\
\-\ one\\:\\ 0\\.010975030252657081\ \(0\)\
\-\ lobe\\:\\ 0\\.01089727653044329\ \(0\)\
\-\ enhancement\\:\\ 0\\.010855396995843774\ \(0\)\
\-\ due\\:\\ 0\\.010807000724894975\ \(0\)\
\-\ these\\:\\ 0\\.010539548303117726\ \(0\)\
\-\ metastatic\\:\\ 0\\.010194831296758723\ \(0\)\
\-\ abdominal\\:\\ 0\\.010122839991100073\ \(0\)\
\-\ in\\:\\ 0\\.009985716354034476\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009953246623847474\ \(0\)\
\-\ increased\\:\\ 0\\.009907510814216378\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009761845980958498\ \(0\)\
\-\ or\\:\\ 0\\.009493106625248413\ \(0\)\
\-\ \\%\\:\\ 0\\.009447019115383924\ \(0\)\
\-\ woman\\:\\ 0\\.009354990272459273\ \(0\)\
\-\ other\\:\\ 0\\.009334779851670373\ \(0\)\
\-\ can\\:\\ 0\\.009185887926393695\ \(0\)\
\-\ it\\:\\ 0\\.009103546846128041\ \(0\)\
\-\ large\\:\\ 0\\.008855651335692322\ \(0\)\
\-\ but\\:\\ 0\\.008637456403002548\ \(0\)\
\-\ lesion\\:\\ 0\\.008249076900476089\ \(0\)\
\-\ \\,\\:\\ 0\\.0076979165549939535\ \(0\)\
\-\ a\\:\\ 0\\.007518479655328935\ \(0\)\
\-\ by\\:\\ 0\\.006743463996421208\ \(0\)\
\-\ be\\:\\ 0\\.006245292527696347\ \(0\)\
\-\ not\\:\\ 0\\.005852221193089742\ \(0\)\
\-\ ct\\:\\ 0\\.005664946224606839\ \(0\)\
\-\ \\:\\:\\ 0\\.0053567526824202134\ \(0\)\
\-\ pain\\:\\ 0\\.004946010272657511\ \(0\)\
\-\ was\\:\\ 0\\.0046837797261312175\ \(0\)\
\-\ this\\:\\ 0\\.004555152669735228\ \(0\)\
\-\ right\\:\\ 0\\.004273136062134676\ \(0\)\
\-\ to\\:\\ 0\\.004048038942587547\ \(0\)\
\-\ the\\:\\ 0\\.003931259280671824\ \(0\)\
\-\ of\\:\\ 0\\.0033129042880944578\ \(0\)\
\-\ and\\:\\ 0\\.0017062464998314547\ \(0\)\
\-\ \\.\\:\\ 0\\.0011777097283479808\ \(0\)\
\-\ with\\:\\ 0\\.0005545221615634585\ \(0\)\
